CAGLIO, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 88
EU - Europa 43
AS - Asia 10
SA - Sud America 1
Totale 142
Nazione #
US - Stati Uniti d'America 87
IT - Italia 13
FR - Francia 11
DE - Germania 4
VN - Vietnam 4
CZ - Repubblica Ceca 3
BE - Belgio 2
DK - Danimarca 2
GB - Regno Unito 2
HK - Hong Kong 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CA - Canada 1
CN - Cina 1
FI - Finlandia 1
IN - India 1
KR - Corea 1
PE - Perù 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 142
Città #
Columbus 11
Santa Cruz 10
Fairfield 9
Rome 4
Ashburn 3
New York 3
Seattle 3
Torino 3
Amsterdam 2
Ann Arbor 2
Barletta 2
Brussels 2
Copenhagen 2
Dong Ket 2
Fleming Island 2
Las Vegas 2
London 2
Monzuno 2
San Jose 2
Santa Clara 2
Woodbridge 2
Annecy 1
Bari 1
Bengaluru 1
Boardman 1
Buffalo 1
Central 1
Gurnee 1
Herndon 1
Houston 1
Krakow 1
Lake Forest 1
Lappeenranta 1
Lexington 1
Lima 1
Los Angeles 1
Marano di Napoli 1
Montreal 1
Neusiedl am See 1
Norfolk 1
Redmond 1
Seodaemun-gu 1
Sha Tin Wai 1
Vancouver 1
Washington 1
Totale 96
Nome #
Clinical and molecular features of epidermal growth factor receptor (Egfr) mutation positive non‐small‐cell lung cancer (nsclc) patients treated with tyrosine kinase inhibitors (tkis): Predictive and prognostic role of co‐mutations, file e27ce431-f183-2581-e053-d805fe0acbaa 60
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab, file e27ce432-291b-2581-e053-d805fe0acbaa 36
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review, file e27ce435-747f-2581-e053-d805fe0acbaa 32
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020, file c0816eac-2a63-4db7-94e9-38df9877527c 12
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience, file 8f2258b7-dc9a-4e76-8ba8-6e3673949448 4
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study, file 0b4ab06a-f161-4b4b-8973-9773f73a72e1 3
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review, file e27ce431-dd16-2581-e053-d805fe0acbaa 1
Totale 148
Categoria #
all - tutte 530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/202249 9 3 1 0 1 4 5 3 0 5 16 2
2022/202360 4 3 15 10 2 5 5 6 3 4 2 1
2023/202434 0 1 0 0 4 0 4 3 3 4 15 0
Totale 148